MAPT and Alzheimer disease: A study of plasma biomarkers in AAs including tau and Aβ42 comparing cognitively unimpaired individuals with Alzheimer's patients found that tau was significantly higher in the AD group and Aβ42 level was not associated with Alzheimer's (26).